Jonathan Wolff is the Alfred Landecker Professor of Values and Public Policy at the Blavatnik School of Government, University of Oxford. His books include Robert Nozick: Property, Justice, and the Minimal State (1991), An Introduction to Political Philosophy (1996, 3rd ed. 2016), Why Read Marx Today? (2002), Disadvantage (with Avner de-Shalit) (2007), Ethics and Public Policy (2011, 2nd ed. 2020), and The Human Right to Health (2012). He has been a member of the Nuffield Council on Bioethics, and has worked on questions of the ethics of risk and the valuation of life and health with the railway and pharmaceutical industries in the UK, as well as the government. He writes a regular column for the Guardian newspaper.

Jonathan Wolff is the Alfred Landecker Professor of Values and Public Policy at the Blavatnik School of Government, University of Oxford. His books include Robert Nozick: Property, Justice, and the Minimal State (1991), An Introduction to Political Philosophy (1996, 3rd ed. 2016), Why Read Marx Today? (2002), Disadvantage (with Avner de-Shalit) (2007), Ethics and Public Policy (2011, 2nd ed. 2020), and The Human Right to Health (2012). He has been a member of the Nuffield Council on Bioethics, and has worked on questions of the ethics of risk and the valuation of life and health with the railway and pharmaceutical industries in the UK, as well as the government. He writes a regular column for the Guardian newspaper.

Jonathan Wolff is the Alfred Landecker Professor of Values and Public Policy at the Blavatnik School of Government, University of Oxford. His books include Robert Nozick: Property, Justice, and the Minimal State (1991), An Introduction to Political Philosophy (1996, 3rd ed. 2016), Why Read Marx Today? (2002), Disadvantage (with Avner de-Shalit) (2007), Ethics and Public Policy (2011, 2nd ed. 2020), and The Human Right to Health (2012). He has been a member of the Nuffield Council on Bioethics, and has worked on questions of the ethics of risk and the valuation of life and health with the railway and pharmaceutical industries in the UK, as well as the government. He writes a regular column for the Guardian newspaper.